StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Other by Quarter

Other ($M)

QuarterlyAnnual

Novartis Other: $72M in Q3 2026, up 18.0% from a year earlier.

Latest, Q3 2026
72
Period ended Sep 30, 2026
Change on a year earlier
+18.0%
61 in Q3 2025
History
17 quarters
Since Q3 2022
Sources
13
Documents cited below

Where the Q3 2026 figure comes from

“|| Other 2 | 72 | 61 | 167 | 202”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K Note 3 & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther ($M)Year on yearSource
Q3 2026Sep 30, 202672+18.0%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202655-24.7%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202640-41.2%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025103+13.2%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025610.0%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025730.0%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202568+30.8%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202491+23.0%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 202461+103.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202473+305.6%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 202452+108.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 202374+138.7%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 202330+11.1%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 202318–Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 202325–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202231–Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Other ($M), quarterly Q3 2022–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/collab-other-activities

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.